Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies

Cited by (1,001)

Items 501–600 of 1,001

1. Activation of the interleukin-23/Th17 axis in major depression: a systematic review and meta-analysis
   Calum D. Moulton, Mantas Kazimieras Malys, Christopher W. P. Hopkins, Anna S. Rokakis, Allan Hunter Young, Nick Powell · 2024 · European Archives of Psychiatry and Clinical Neuroscience
2. Research Trends of Rheumatoid Arthritis and Depression from 2019 to 2023: A Bibliometric Analysis
   Yan Zhao, Guangyao Chen, Meng Fang · 2024 · Journal of Multidisciplinary Healthcare
3. Systemic inflammation as a mediator in the link between obesity and depression: Evidence from a nationwide cohort study
   Xiaoqing Wang, Xinyue Liang, Ming Jiang, Ling Wei, Xiangpeng Shi, Fang Fang, Jing Cang · 2025 · BMC Psychiatry
4. Regulation of inflammation by Chaihu-Shugan-San: Targeting the IL-17/ NF-κB pathway to combat breast cancer-related depression
   Zhongyuan Qu, Huimin Li, Fan Qiang, Kai‐Li Liu, Shuang Wu, Jianli Li, Xiang Zou · 2025 · Phytomedicine
5. Peripheral Immune-Inflammatory Pathways in Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: Exploring Their Potential as Treatment Targets
   Abbas Firras Almulla, Michael H. J. Maes · 2025 · CNS Drugs
6. Gut–Brain Axis in Mood Disorders: A Narrative Review of Neurobiological Insights and Probiotic Interventions
   Gilberto Uriel Rosas-Sánchez, León Jesús Germán-Ponciano, Abraham Puga-Olguín, Mario Eduardo Flores-Soto, Angelica Y Nápoles-Medina, José Luis Muñoz‐Carrillo, Juan Francisco Rodríguez‐Landa, César Soria-Fregozo · 2025 · Biomedicines
7. Astroglial Mechanisms of Ketamine Action Include Reduced Mobility of Kir4.1-Carrying Vesicles
   Matjaž Stenovec, Mićo Božić, Samo Pirnat, Robert Zorec · 2019 · Neurochemical Research
8. Plasma cytokine levels in patients with chronic alcohol overconsumption: Relations to gut microbiota markers and clinical correlates
   Steinar Traae Bjørkhaug, Sudan Prasad Neupane, Jørgen G. Bramness, Håvard Aanes, Viggo Skar, Asle W. Medhus, Jørgen Valeur · 2019 · Alcohol
9. Subtyping late-life depression according to inflammatory and metabolic dysregulation: a prospective study
   K. J. E. Kokkeler, R. M. Marijnissen, K. J. Wardenaar, D. Rhebergen, R. H. S. van den Brink, R. C. van der Mast, Richard C. Oude Voshaar · 2020 · Psychological Medicine
10. Investigating whether depressed youth exhibiting elevated C reactive protein perform worse on measures of executive functioning, verbal fluency and episodic memory in a large, population based sample of Dutch adolescents
    Naoise Mac Giollabhui, Lauren B. Alloy, Catharina Annette Hartman · 2020 · Brain Behavior and Immunity
11. Inflammatory Proteins and Clinical Response to Psychological Therapy in Patients with Depression: An Exploratory Study
    Rebecca Strawbridge, Lindsey Marwood, Sinéad King, Allan Hunter Young, Carmine Maria Pariante, Alessandro Colasanti, Anthony James Cleare · 2020 · Journal of Clinical Medicine
12. Association of mentally-active and mentally-passive sedentary behaviour with depressive symptoms among adolescents
    André O. Werneck, Erin Hoare, Brendon Stubbs, Esther M. F. van Sluijs, Kirsten L. Corder · 2021 · Journal of Affective Disorders
13. No increase in inflammation in late-life major depression screened to exclude physical illness
    Eline T. Luning Prak, Thomas G. Brooks, Walid Makhoul, Joanne C. Beer, Ling Zhao, Tommaso Girelli, Carsten Skarke, Yvette I. Sheline · 2022 · Translational Psychiatry
14. Adipose Tissue Compartments, Inflammation, and Cardiovascular Risk in the Context of Depression
    Britta Stapel, Maria Jelinic, Grant Raymond Drummond, Dagmar Hartung, Kai G. Kahl · 2022 · Frontiers in Psychiatry
15. Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort
    Jonah F. Byrne, Colm Healy, David Mongan, Subash Raj Susai, Stanley Zammit, Melanie Föcking, Mary D Cannon, David Cotter · 2022 · Translational Psychiatry
16. Sleep time and quality associated with depression and social anxiety among children and adolescents aged 6–18 years, stratified by body composition
    Wen Yuan, Li Chen, Yu Wu, Binbin Su, Jieyu Liu, Yi Zhang, Manman Chen, Ying Ma, Tongjun Guo, Xinxin Wang et al. · 2023 · Journal of Affective Disorders
17. A randomized controlled trial of mindfulness-based cognitive therapy for major depressive disorder in undergraduate students: Dose- response effect, inflammatory markers and BDNF
    Wei Liu, Jing Yuan, Yun Wu, Xu Li, Xin Wang, Junyu Meng, Yujun Wei, Yan Zhang, Chuanyuan Kang, Jianzhong Yang · 2023 · Psychiatry Research
18. Association between immune-inflammation-based prognostic index and depression: An exploratory cross-sectional analysis of NHANES data
    Yawei Zheng, Kailin Yin, Li Li, Xintong Wang, Hui Li, Wenlei Li, Zhuyuan Fang · 2024 · Journal of Affective Disorders
19. Revisiting the tryptophan-serotonin deficiency and the inflammatory hypotheses of major depression in a biopsychosocial approach
    Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Robert J. Breitenecker, Hans‐Bernd Rothenhäusler, Christoph Robier, Mária Baranyi, Simon Theokas, Andreas Meinitzer · 2017 · PeerJ
20. Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression
    Giuseppe Fanelli, Francesco Benedetti, Sheng‐Min Wang, Soo-Jung Lee, Tae‐Youn Jun, Prakash S. Masand, Ashwin A. Patkar, Changsu Han, Alessandro Serretti, Chi‐Un Pae et al. · 2019 · Journal of Affective Disorders
21. Long COVID-19: Psychological symptoms in COVID-19 and probiotics as an adjunct therapy
    Angel Yun-Kuan Thye, Loh Teng‐Hern Tan, Jodi Woan‐Fei Law, Priyia Pusparajah, Vengadesh Letchumanan · 2022 · Progress In Microbes & Molecular Biology
22. Post-traumatic stress disorder, dyssomnias, and metabolic syndrome
    Victoria A Serhiyenko, Volodymyr B. Sehin, V.І. Pankiv, Alexandr A. Serhiyenko · 2024 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
23. Functional resting state connectivity is differentially associated with IL-6 and TNF-α in depression and in healthy controls
    Christian Nikolaus Schmitz, Gebhard Sammer, Elena Neumann, Carlo R. Blecker, Gerhard Gründer, Hana Adolphi, Eva Kathrin Lamadé, Bruno Pedraz Petrozzi · 2025 · Scientific Reports
24. An Exploratory Pilot Study with Plasma Protein Signatures Associated with Response of Patients with Depression to Antidepressant Treatment for 10 Weeks
    Eun Young Kim, Hee‐Sung Ahn, Min Young Lee, Jiyoung Yu, Jeonghun Yeom, Hwangkyo Jeong, Hophil Min, Hyun Jeong Lee, Kyunggon Kim, Yong Min Ahn · 2020 · Biomedicines
25. Toll-like receptor 4-mediated cytokine synthesis and post-stroke depressive symptoms
    Michał Korostyński, Dżesika Hoinkis, Marcin Piechota, Sławomir Gołda, Joanna Pera, Agnieszka Słowik, Tomasz Dziedzic · 2021 · Translational Psychiatry
26. The impact of the COVID-19 pandemic on frozen shoulder incidence rates and severity
    Joachim Demyttenaere, Oisin Martyn, Ruth A. Delaney · 2022 · Journal of Shoulder and Elbow Surgery
27. Liver and inflammatory biomarker relationships to depression symptoms in healthy older adults
    Karen M. Savage, Claire Porter, Emily R. Bunnett, Maher Hana, Andrew P. Keegan, Edward Ogden, Con K. K. Stough, Andrew Pipingas · 2023 · Experimental Gerontology
28. Exploring the impact of ketogenic diet on multiple sclerosis: obesity, anxiety, depression, and the glutamate system
    José Enrique de la Rubia Ortí, María Cuerda‐Ballester, Claudia Emmanuela Sanchis-Sanchis, José María Lajara-Romance, Esther Navarro-Illana, María Pilar García-Pardo · 2023 · Frontiers in Nutrition
29. Imaging genetics paradigms in depression research: Systematic review and meta-analysis
    Lícia Pachêco Pereira, Cristiano André Köhler, Brendon Stubbs, Kamilla Woznica Miskowiak, Gerwyn Morris, Bárbara P. de Freitas, Trevor Thompson, Brisa Simões Fernandes, André R. Brunoni, Michael H. J. Maes et al. · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
30. CD8+ T cells promote cytokine responses to stress
    Sarah M. Clark, Chang Hwa Song, Xin Li, Achsah Dorsey Keegan, Leonardo H. Tonelli · 2018 · Cytokine
31. Low tumor necrosis factor‐α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder
    Annamari Sorri, Kaija Järventausta, Olli Kampman, Kai A. Lehtimäki, Minna Björkqvist, Kati Tuohimaa, Mari Hämäläinen, Eeva Moilanen, Esa V. J. Leinonen · 2018 · Brain and Behavior
32. The effect of Xinkeshu tablets on depression and anxiety symptoms in patients with coronary artery disease: Results from a double-blind, randomized, placebo-controlled study
    Huan Ma, Yu Wang, Yunlian Xue, Daozheng Huang, Yong-Jie Kong, Xujie Zhao, Minzhou Zhang · 2019 · Biomedicine & Pharmacotherapy
33. Association between high-sensitivity C-reactive protein levels and depression: Moderation by age, sex, obesity, and aerobic physical activity
    Song Heui Cho, Ji‐Eun Lim, Jiseung Lee, Jee Soo Lee, Hyun‐Ghang Jeong, Moon‐Soo Lee, Young‐Hoon Ko, Changsu Han, Byung‐Joo Ham, Kyu‐Man Han · 2021 · Journal of Affective Disorders
34. Signaling networks in inflammatory pathways and risk for suicidal behavior
    Rengasamy, Manivel, Zhong, Yongqi, Marsland, Anna, Chen, Kehui, Douaihy, Antoine, Brent, David, Melhem, Nadine M. · 2020 · Brain, Behavior, & Immunity - Health
35. Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder
    Nisat Sarmin, A. S. M. Roknuzzaman, Tashfiya Zaman Mouree, Md. Rabiul Islam, Zobaer Al Mahmud · 2024 · Scientific Reports
36. Inflammation and immune system pathways as biological signatures of adolescent depression—the IDEA-RiSCo study
    Valentina Zonca, Moira Marizzoni, Samantha Saleri, Zuzanna Zajkowska, Pedro H. Manfro, Laila Souza, Anna Carolina Viduani, Luca Sforzini, Johnna R. Swartz, Helen Louise Fisher et al. · 2024 · Translational Psychiatry
37. Prospective associations between hsCRP and GlycA inflammatory biomarkers and depression: The Brazilian longitudinal study of adult health (ELSA-Brasil)
    André R. Brunoni, Giovanni Abrahão Salum, Maurício Scopel Hoffmann, Alessandra Carvalho Goulart, Sandhi Maria Barreto, Scheine Canhada, Andre Ferrer Carvalho, Ai Koyanagi, Viviane Cálice-Silva, Paulo A. Lotufo et al. · 2020 · Journal of Affective Disorders
38. Mechanisms and treatment of late-life depression
    Alexopoulos, George S. · 2021 · Focus
39. Inflammation, depressive symptoms, and emotion perception in adolescence
    Amy T. Peters, Xinguo Ren, Katie L. Bessette, Nevita George, Leah R. Kling, Brandon Thies, Amy E. West, Scott A. Langenecker, Ghanshyam N. Pandey · 2021 · Journal of Affective Disorders
40. Elevated C-Reactive Protein in Alzheimer’s Disease Without Depression in Older Adults: Findings From the Health and Retirement Study
    Ginny Natale, Sean Clouston, Dylan M. Smith · 2021 · The Journals of Gerontology Series A
41. The Role of Neutrophil Extracellular Traps in Lipopolysaccharide-Induced Depression-like Behaviors in Mice
    Yue Kong, Guiqin He, Xiaolin Zhang, Jin Li · 2021 · Brain Sciences
42. Dissection of depression heterogeneity using proteomic clusters
    Marije van Haeringen, Yuri Milaneschi, Femke Lamers, Brenda W.J.H. Penninx, Rick Jansen · 2022 · Psychological Medicine
43. Prenatal and Childhood Immuno-Metabolic Risk Factors for Adult Depression and Psychosis
    Nils Kappelmann, Benjamin I. Perry, Golam Mohammed Khandaker · 2022 · Harvard Review of Psychiatry
44. Inflammatory Cytokines Changed in Patients With Depression Before and After Repetitive Transcranial Magnetic Stimulation Treatment
    Qiang Wang, Lingyun Zeng, Wenjuan Hong, Mingying Luo, Nan Zhao, Xiaofen Hu, Meili Shi, Jing Qiu, Yanmin Shen, Xiuju Teng et al. · 2022 · Frontiers in Psychiatry
45. The prospective relationship between subjective aging and inflammation: Evidence from the health and retirement study
    Yannick Stéphan, Angelina R. Sutin, Martina Luchetti, Antonio Terracciano · 2022 · Psychophysiology
46. Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study
    Kai‐Chun Yang, Mu‐N Liu, Ying‐Jay Liou, Li‐Yu Hu, Bang‐Hung Yang, Yuan-Hwa Chou · 2021 · Journal of Psychiatric Research
47. Sex‐specific peripheral and central responses to stress‐induced depression and treatment in a mouse model
    Deonaraine, Kristina K., Wang, Qian, Cheng, Haoxiang, Chan, Kenny L., Lin, Hsiao‐Yun, Liu, Kalena, Parise, Lyonna F., Cathomas, Flurin, Leclair, Katherine B., Flanigan, Meghan E. et al. · 2020 · Journal of Neuroscience Research
48. Phenome-wide investigation of bidirectional causal relationships between major depressive disorder and common human diseases
    Wen-xi Sun, Ancha V. Baranova, Dongming Liu, Hongbao Cao, Xiaobin Zhang, Fuquan Zhang · 2024 · Translational Psychiatry
49. Resistance training reduces depressive and anxiety symptoms in older women: a pilot study
    Paolo M. Cunha, André O. Werneck, João Pedro Nunes, Brendon Stubbs, Felipe Barreto Schuch, Gabriel Kunevaliki, Liye Zou, Edílson Serpeloni Cyrino · 2021 · Aging & Mental Health
50. Inflammatory proteins and miRNA-144-5p in patients with depression, anxiety, or stress- and adjustment disorders after psychological treatment
    Kristina Sundquist, Ashfaque Ahmed Memon, Karolina Palmér, Jan Sundquist, Xiao Wang · 2021 · Cytokine
51. The Combination of Serum BDNF, Cortisol and IFN-Gamma Can Assist the Diagnosis of Major Depressive Disorder
    Suzhen Chen, Yuqun Zhang, Yonggui Yuan · 2021 · Neuropsychiatric Disease and Treatment
52. Scutellarin alleviates depression-like behaviors induced by LPS in mice partially through inhibition of astrocyte-mediated neuroinflammation
    Liang Lu, Liu-kun Yang, Jiao Yue, Xin‐shang Wang, Jingyu Qi, Fan Yang, Ban Feng, Shui‐bing Liu · 2021 · Neuroscience Letters
53. Meta‐analysis of peripheral mean platelet volume in patients with mental disorders: Comparisons in depression, anxiety, bipolar disorder, and schizophrenia
    Zhichao Chen, Jing Wang, Ciriaco Carru, Stefania Sedda, Alessandra Matilde Nivoli, Zhi Li · 2023 · Brain and Behavior
54. Biomarkers of Postpartum Depression: A Narrative Review
    Stefan Modzelewski, Aleksandra Julia Oracz, Kamila Iłendo, Aleksandra Sokół, Napoleon Waszkiewicz · 2023 · Journal of Clinical Medicine
55. NLRP3 inflammatory pathway. Can we unlock depression?
    Ghazaleh Ghaffaripour Jahromi, Sepideh Razi, Nima Rezaei · 2023 · Brain Research
56. Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities
    Luana Meller Manosso, Luciano A. Duarte, Nicoly S. Martinello, Gisiane B. de Mathia, Gislaine Z. Réus · 2023 · CNS & Neurological Disorders - Drug Targets
57. Upregulation of proBDNF/p75NTR signaling in immune cells and its correlation with inflammatory markers in patients with major depression
    Chunrui Yang, Rui Liang, Yuan Liu, Fanjie Meng, Fiona H. Zhou, Xiao‐Yang Zhang, Li Ning, Zhi‐Qiang Wang, Shuang Liu, Xin‐Fu Zhou · 2023 · The FASEB Journal
58. Clinical value and mechanistic analysis of HIIT on modulating risk and symptoms of depression: A systematic review
    Xu Yuxiang, Yongjie Li, Changqing Wang, Tingting Han, Wu Yue, Song Wang, Jianshe Wei · 2024 · International Journal of Clinical and Health Psychology
59. Depression and incident hip fracture
    So Young Kim, Joon Kyu Lee, Dong Jun Oh, Il Gyu Kong, Hyo Geun Choi · 2019 · Medicine
60. Different cytokine patterns associate with melancholia severity among inpatients with major depressive disorder
    Lucas Primo de Carvalho Alves, Neusa Sica da Rocha · 2020 · Therapeutic Advances in Psychopharmacology
61. The Association of Grip Strength with Depressive Symptoms among Middle-Aged and Older Adults with Different Chronic Diseases
    Priscila Marconcin, Miguel Peralta, Gérson Ferrari, Margarida Gaspar de Matos, Margarida Espanha, Eugenia Murawska‐Ciałowicz, Adilson Marques · 2020 · International Journal of Environmental Research and Public Health
62. Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial
    Mostafa Farajollahi-Moghadam, Hossein Sanjari-Moghaddam, Maryam Ghazizadeh Hasemi, Zahra Sanatian, Ali Talaeı, Shahin Akhondzadeh · 2021 · International Clinical Psychopharmacology
63. In Vitro Effects of Cannabidiol on Activated Immune–Inflammatory Pathways in Major Depressive Patients and Healthy Controls
    Muanpetch Rachayon, Ketsupar Jirakran, Pimpayao Sodsai, Siriwan Klinchanhom, Atapol Sughondhabirom, Kitiporn Plaimas, Apichat Suratanee, Michael H. J. Maes · 2022 · Pharmaceuticals
64. Electroacupuncture attenuates depressive-like behaviors in poststroke depression mice through promoting hippocampal neurogenesis and inhibiting TLR4/NF-κB/NLRP3 signaling pathway
    Ming Li, Fang Yang, Xiaoling Zhang, Hong Yang, Xingjin He, Zhongnan Mao, Liya Mao · 2024 · Neuroreport
65. Decoding serotonin: the molecular symphony behind depression
    Yue Long Shu, Lei Tian, Xing Wang, Tinyang Meng, Shouyang Yu, Yulan Li · 2025 · Frontiers in Cellular Neuroscience
66. Evidence of upregulation of the cholinergic anti-inflammatory pathway in late-life depression
    Nunzio Pomara, Davide Bruno, Chelsea Reichert Plaska, Anilkumar Pillai, Jaime Ramos‐Cejudo, Ricardo S. Osorio, Bruno Pietro Imbimbo, Amanda Heslegrave, Henrik Zetterberg, Kaj Blennow · 2021 · Journal of Affective Disorders
67. Intra-individual state-dependent comparison of plasma mitochondrial DNA copy number and IL-6 levels in patients with bipolar disorder
    Yuki Kageyama, Yasuhiko Deguchi, Takaoki Kasahara, Munehide Tani, Kenji Kuroda, Koki Inoue, Tadafumi Kato · 2021 · Journal of Affective Disorders
68. Immune signature of multiple sclerosis-associated depression
    Jelena Brasanac, Caren Ramien, Stefanie Gamradt, Aline Taenzer, Laura Glau, Kristin Ritter, Kostas Patas, Agorastos Agorastos, Klaus Wiedemann, Cüneyt Demiralay et al. · 2021 · Brain Behavior and Immunity
69. Estrogen, the Peripheral Immune System and Major Depression – A Reproductive Lifespan Perspective
    Elizabeth B. Engler-Chiurazzi, Wesley H. Chastain, Kailen K. Citron, Lillian E. Lambert, Divya N. Kikkeri, Sharhana S. Shrestha · 2022 · Frontiers in Behavioral Neuroscience
70. A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study
    Niyazi Samet Yılmaz, Bayram Şen, Rukiye Filiz Karadag, Selçuk Aslan, İrem Ekmekçi Ertek, Aruz Bozkurt, Saba Çiçek, Abdullah Bolu, Huseyin Ucar, Cemal Koçak et al. · 2022 · Journal of Neural Transmission
71. Biomarker opportunities in the treatment of cancer-related depression
    Aliza A. Panjwani, Stefan Aguiar, Bryan Gascon, David G. Brooks, Madeline Li · 2022 · Trends in Molecular Medicine
72. In major dysmood disorder, physiosomatic, chronic fatigue and fibromyalgia symptoms are driven by immune activation and increased immune-associated neurotoxicity
    Michael H. J. Maes, Abbas Firras Almulla, Bo Zhou, Ali Abbas Abo Algon, Pimpayao Sodsai · 2024 · Scientific Reports
73. Metabolic Status Influences Probiotic Efficacy for Depression—PRO-DEMET Randomized Clinical Trial Results
    O. Gawlik-Kotelnicka, A. Margulska, Kacper Płeska, A. Skowrońska, D. Strzelecki · 2024 · Nutrients
74. Do Defective Immune System-Mediated Myelination Processes Increase Postpartum Psychosis Risk?
    Paola Dazzan, Montserrat Fusté, William Davies · 2018 · Trends in Molecular Medicine
75. The antidepressant effect of testosterone: An effect of neuroplasticity?
    A. Walther, J. Wasielewska, Odette Leiter · 2019 · Neurology Psychiatry and Brain Research
76. Associations between mental and oral health in Spain: a cross-sectional study of more than 23,000 people aged 15 years and over
    Louis Jacob, Guillermo Felipe López Sánchez, Andre Ferrer Carvalho, Jae Il Shin, Hans Y. Oh, Lin Yang, Nicola Veronese, Pınar Soysal, Igor Grabovac, Ai Koyanagi et al. · 2020 · Journal of Affective Disorders
77. Bupropion monotherapy alters neurotrophic and inflammatory markers in patients of major depressive disorder
    Sana Tafseer, Rachna Gupta, Rafat S. Ahmad, Seema Jain, M S Bhatia, Lalit K. Gupta · 2020 · Pharmacology Biochemistry and Behavior
78. Ketamine, benzoate, and sarcosine for treating depression
    Yu‐Jung Cheng, Chieh‐Hsin Lin, Hsien‐Yuan Lane · 2022 · Neuropharmacology
79. Premature T cell aging in major depression: A double hit by the state of disease and cytomegalovirus infection
    Maria S. Simon, Magdalini Ioannou, Gara Arteaga-Henríquez, Annemarie J. M. Wijkhuijs, Raf Berghmans, Richard Musil, Norbert Müller, Hemmo A. Drexhage · 2023 · Brain Behavior & Immunity - Health
80. Identifying circulating biomarkers for major depressive disorder
    En Zhang, Zhongfei Huang, Zongjun Zang, Xin Qiao, Jiaxin Yan, Xuefei Shao · 2023 · Frontiers in Psychiatry
81. Characteristics of gut microbiota and its correlation with hs-CRP and somatic symptoms in first-episode treatment-naive major depressive disorder.
    Peng-Hong Liu, Lin Jing, Feng-Tao Guo, Yunfan Xu, Jun-Xiang Cheng, Sha-Sha Liu, Lixin Liu, Zhifen Liu, Kerang Zhang, Ning Sun · 2024 · Journal of Affective Disorders
82. Major depressive disorder, neuroticism, suicidal behaviors, and depression severity are associated with cytokine networks and their intricate interactions with metabolic syndrome
    Michael H. J. Maes, Ketsupar Jirakran, Asara Vasupanrajit, Bo Zhou, Chavit Tunvirachaisakul, Abbas Firras Almulla · 2024 · Journal of Psychosomatic Research
83. Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges
    Michael J. Lucido, Boadie Waid Dunlop · 2025 · Brain Sciences
84. Variation in chemokines plasma concentrations in primary care depressed patients associated with Internet-based cognitive-behavioral therapy
    Pablo Romero‐Sanchiz, Raquel Nogueira‐Arjona, Pedro Fernando Araos, Antonia Serrano, Vicente Barrios, Jesús Argente, Nuria García‐Marchena, Antonio López-Téllez, Silvia Rodríguez-Moreno, Fermín Mayoral et al. · 2020 · Scientific Reports
85. Association of Chemokine (C-C Motif) Receptor 5 and Ligand 5 with Recovery from Major Depressive Disorder and Related Neurocognitive Impairment
    Olivia Bauer, Vladimir M. Milenkovic, Sven Hilbert, Nina Sarubin, Johannes Weigl, Lisa‐Marie Bahr, Thomas Christian Wetter, Barbara Heckel, Christian H. Wetzel, Rainer Rupprecht et al. · 2020 · NeuroImmunoModulation
86. Correlation between Mild Traumatic Brain Injury-Induced Inflammatory Cytokines and Emotional Symptom Traits: A Systematic Review
    Shazia Malik, Omar Alnaji, Mahnoor Malik, Teresa Gambale, Michel Piers Rathbone · 2022 · Brain Sciences
87. Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients
    Hursitoglu, Onur, Kurutas, Ergul Belge, Strawbridge, Rebecca, Oner, Erkan, Gungor, Meltem, Tuman, Taha Can, Uygur, Omer Faruk · 2023 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
88. Effects of various statins on depressive symptoms: a network meta-analysis
    Lee, Ming-Chia, Peng, Tzu-Rong, Chen, Bi-Li, Lee, Chih-Hsin, Wang, Jann-Yuan, Lai, Cheng-Pin, Lee, Jen-Ai, Chen, Shih-Ming, Shiang, Jeng-Chuan · 2021 · Journal of Affective Disorders
89. Peripheral protein inflammatory biomarkers in bipolar disorder and major depressive disorder: A systematic review and meta-analysis
    Ridhi Gopalakrishnan, Yifan Wang, Flávio Pereira Kapczinski, Benicio Noronha Frey, Bianca Wollenhaupt-Aguiar · 2025 · Journal of Affective Disorders
90. Peripheral Biomarkers of Inflammation in Depression: Evidence from Animal Models and Clinical Studies
    João Paulo Brás, Soraia Filipa Tavares Pinto, Maria Inês Almeida, Joana Prata, Orlando von Doellinger, Rui C. Coelho, Mário Adolfo Barbosa, Susana Gomes Santos · 2019 · Methods in molecular biology
91. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia
    Guillaume B. Fond, Jean‐Arthur Micoulaud‐Franchi, Mélanie Faugère, Laurent Boyer, Catherine Faget, Christophe Lançon, Raphaëlle Marie Richieri, Michel Cermolacce · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
92. Lifetime pathogen burden, inflammatory markers, and depression in community-dwelling older adults
    Yanxia Lu, Bao-Peng Liu, Crystal TY Tan, Fang Pan, Anis Larbi, Tze Pin Ng · 2022 · Brain Behavior and Immunity
93. Association of Dietary Inflammatory Index (DII) and depression in the elderly over 55 years in Northern China: analysis of data from a multicentre, cohort study
    Ruiqiang Li, Wenqiang Zhan, Xin Huang, Zechen Zhang, Meiqi Zhou, Wei Bao, Feifei Huang, Yuxia Ma · 2022 · BMJ Open
94. The Association Between Grip Strength and Depression Among Adults Aged 60 Years and Older: A Large-Scaled Population-Based Study From the Longitudinal Aging Study in India
    Jinbao Wang, Xianghong Zhou, Shi Qiu, Linghui Deng, Jiakun Li, Lu Yang, Qiang Wei, Birong Dong · 2022 · Frontiers in Aging Neuroscience
95. Towards a multilevel model of major depression: genes, immuno-metabolic function, and cortico-striatal signaling
    Elisabeth R. Paul, Lars Östman, Markus A Heilig, Helen S. Mayberg, J. Paul Hamilton · 2023 · Translational Psychiatry
96. Changes in Adipokine, Resitin, and BDNF Concentrations in Treatment-Resistant Depression after Electroconvulsive Therapy
    Agnieszka Permoda-Pachuta, Magda Malewska-Kasprzak, Maria Skibińska, Krzysztof Rzepski, Monika Dmitrzak‐Węglarz · 2023 · Brain Sciences
97. Inflammatory changes in the plasma and cerebrospinal fluid of patients with persistent pain and postpartum depression after elective Cesarean delivery: an exploratory prospective cohort study
    Mary Yurashevich, Mary L. Cooter, S. Sims, Hon Sen Tan, Miles Berger, Ru‐Rong Ji, Ashraf Samir Habib · 2023 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
98. Effects of Lycium barbarum polysaccharide on cytokines in adolescents with subthreshold depression: a randomized controlled study
    Xiaoyue Li, Tao Liu, Xuan Mo, Runhua Wang, Xueyan Kong, Robin Shao, Roger S. McIntyre, Kwok‐Fai So, Kangguang Lin · 2023 · Neural Regeneration Research
99. Assessing causality between chronic obstructive pulmonary disease with depression: A bidirectional Mendelian randomization study
    Ang Liu, Ping-Yang Hong, Bin Su, Jian-Hua Wu, Zhiyuan Chen · 2024 · Journal of Affective Disorders
100. Acute and chronic effects of physical exercise in inflammatory biomarkers in people with depression: A systematic review with meta-analysis
     Maria Eduarda Adornes Guimarães, Viviane Derhon, Luís Ulisses Signori, Britta Seiffer, Sebastian Wolf, Felipe Barreto Schuch · 2024 · Journal of Psychiatric Research